New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
'RethiNKing' which immune cells are the best weapon against lung cancer

'RethiNKing' which immune cells are the best weapon against lung cancer

by Walter and Eliza Hall InstituteAustralian researchers have identified 'natural killer' cells as an important component of anti-tumour immunity to lung cancer.Image: sections of lung co
Oncology April 01,2024
'RethiNKing' which immune cells are the best weapon against lung cancer

'RethiNKing' which immune cells are the best weapon against lung cancer

by Walter and Eliza Hall InstituteAustralian researchers have identified 'natural killer' cells as an important component of anti-tumour immunity to lung cancer.Image: sections of lung co
Oncology April 01,2024
'Missing self' contributes to organ rejection after transplantation

'Missing self' contributes to organ rejection after transplantation

by American Society of NephrologyCredit: Pixabay/CC0 Public DomainImmune cells called natural killer cells contribute to organ rejection after transplantation because they miss "self" p
Nephrology & Urology April 01,2024
'Missing self' contributes to organ rejection after transplantation

'Missing self' contributes to organ rejection after transplantation

by American Society of NephrologyCredit: Pixabay/CC0 Public DomainImmune cells called natural killer cells contribute to organ rejection after transplantation because they miss "self" p
Nephrology & Urology April 01,2024
Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G
Oncology April 01,2024
Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G
Oncology April 01,2024
Drug that blocks blood vessel growth could treat rare sarcomas

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti
Oncology April 01,2024
Drug that blocks blood vessel growth could treat rare sarcomas

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti
Oncology April 01,2024
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Oncology April 01,2024
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Oncology April 01,2024
Blocking a survival mechanism could tackle melanoma treatment resistance

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t
Oncology April 01,2024
Blocking a survival mechanism could tackle melanoma treatment resistance

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t
Oncology April 01,2024
Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

by American Association for Cancer ResearchElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainAn analysis of cervical precan
Oncology April 01,2024
Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

by American Association for Cancer ResearchElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainAn analysis of cervical precan
Oncology April 01,2024
Self-testing cervical cancer screening could save Māori women's lives

Self-testing cervical cancer screening could save Māori women's lives

by Victoria University of WellingtonElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainCervical cancer is the second leading
Oncology April 01,2024
Self-testing cervical cancer screening could save Māori women's lives

Self-testing cervical cancer screening could save Māori women's lives

by Victoria University of WellingtonElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainCervical cancer is the second leading
Oncology April 01,2024
Autism-associated gene appears to alter brain cell identity in the hippocampus

Autism-associated gene appears to alter brain cell identity in the hippocampus

by UT Southwestern Medical CenterThis image, obtained from a mouse brain using a brightfield microscope, shows the richly diverse cells of the hippocampus pseudocolored with different hues. Maria
Oncology April 01,2024
Autism-associated gene appears to alter brain cell identity in the hippocampus

Autism-associated gene appears to alter brain cell identity in the hippocampus

by UT Southwestern Medical CenterThis image, obtained from a mouse brain using a brightfield microscope, shows the richly diverse cells of the hippocampus pseudocolored with different hues. Maria
Oncology April 01,2024
Blocking inflammatory pathway key to preventing brain metastasis from melanoma

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,
Oncology April 01,2024
Blocking inflammatory pathway key to preventing brain metastasis from melanoma

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,
Oncology April 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com